List of Human Genome Sciences patents

Patents where

Current Assignee

Name

Human Genome Sciences

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7375192 Antibodies that specifically bind to chemokine beta-4	Patent 7375192 was granted and assigned to Human Genome Sciences on May, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7375192	May 20, 2008
‌ US Patent 7189820 Antibodies against tumor necrosis factor delta (APRIL)	Patent 7189820 was granted and assigned to Human Genome Sciences on March, 2007 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7189820	March 13, 2007
‌ US Patent 7514079 Antibodies that specifically bind to neurokinin B	Patent 7514079 was granted and assigned to Human Genome Sciences on April, 2009 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7514079	April 7, 2009
‌ US Patent 7220840 Antibodies that immunospecifically bind to B lymphocyte stimulator protein	Patent 7220840 was granted and assigned to Human Genome Sciences on May, 2007 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7220840	May 22, 2007
‌ US Patent 7138501 Antibodies that immunospecifically bind BLyS	Patent 7138501 was granted and assigned to Human Genome Sciences on November, 2006 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7138501	November 21, 2006
‌ US Patent 7605236 Antibodies that immunospecifically bind to B lymphocyte stimulator protein	Patent 7605236 was granted and assigned to Human Genome Sciences on October, 2009 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7605236	October 20, 2009
‌ US Patent 7597886 Tumor necrosis factor-gamma	Patent 7597886 was granted and assigned to Human Genome Sciences on October, 2009 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7597886	October 6, 2009
‌ US Patent 7087225 Methods and compositions for treating metabolic bone diseases relating to human endokine alpha	Patent 7087225 was granted and assigned to Human Genome Sciences on August, 2006 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7087225	August 8, 2006
‌ US Patent 8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein	Patent 8101181 was granted and assigned to Human Genome Sciences on January, 2012 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	8101181	January 24, 2012
‌ US Patent 7393943 Polynucleotides encoding a human chemotactic cytokine I	Patent 7393943 was granted and assigned to Human Genome Sciences on July, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7393943	July 1, 2008
‌ US Patent 7820798 Tumor necrosis factor-gamma	Patent 7820798 was granted and assigned to Human Genome Sciences on October, 2010 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7820798	October 26, 2010
‌ US Patent 7122639 Chemokine alpha-2 antibodies	Patent 7122639 was granted and assigned to Human Genome Sciences on October, 2006 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7122639	October 17, 2006
‌ US Patent 7141547 Albumin fusion proteins comprising GLP-1 polypeptides	Patent 7141547 was granted and assigned to Human Genome Sciences on November, 2006 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7141547	November 28, 2006
‌ US Patent 7041802 Peptidoglycan recognition proteins	Patent 7041802 was granted and assigned to Human Genome Sciences on May, 2006 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7041802	May 9, 2006
‌ US Patent 7368531 Human secreted proteins	Patent 7368531 was granted and assigned to Human Genome Sciences on May, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7368531	May 6, 2008
‌ US Patent 7368527 HADDE71 polypeptides	Patent 7368527 was granted and assigned to Human Genome Sciences on May, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7368527	May 6, 2008
‌ US Patent 7368244 Peptidoglycan recognition proteins	Patent 7368244 was granted and assigned to Human Genome Sciences on May, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7368244	May 6, 2008
‌ US Patent 8093363 Tumor necrosis factor-gamma	Patent 8093363 was granted and assigned to Human Genome Sciences on January, 2012 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	8093363	January 10, 2012
‌ US Patent 7393650 Method of producing an antibody to G-protein parathyroid hormone receptor HLTDG74	Patent 7393650 was granted and assigned to Human Genome Sciences on July, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7393650	July 1, 2008
‌ US Patent 7763244 Antibodies that specifically bind to Reg IV	Patent 7763244 was granted and assigned to Human Genome Sciences on July, 2010 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7763244	July 27, 2010
‌ US Patent 7109302 Antibodies that specifically bind to GMAD	Patent 7109302 was granted and assigned to Human Genome Sciences on September, 2006 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7109302	September 19, 2006
‌ US Patent 7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10	Patent 7175988 was granted and assigned to Human Genome Sciences on February, 2007 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7175988	February 13, 2007
‌ US Patent 7425622 Antibodies against C3a receptor	Patent 7425622 was granted and assigned to Human Genome Sciences on September, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7425622	September 16, 2008
‌ US Patent 7348003 Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors	Patent 7348003 was granted and assigned to Human Genome Sciences on March, 2008 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7348003	March 25, 2008
‌ US Patent 7501123 Human G-protein chemokine receptor (CCR5) HDGNR10	Patent 7501123 was granted and assigned to Human Genome Sciences on March, 2009 by the United States Patent and Trademark Office.	Human Genome Sciences	United States Patent and Trademark Office	7501123	March 10, 2009

...

Results per page:

273 results

0 selected

273 results

0 selected